Corporate Misconduct Accountability Project
Young America Capital LLC · Regulatory Settlement – Letter of Acceptance, Waiver, and Consent
Young America Capital Ignored Money Laundering Warnings for Years
The investment bank advised cannabis and biotech companies while its own manuals falsely claimed no duty to monitor suspicious transactions, leaving criminal proceeds unchecked from 2020 to 2025.
HIGH SEVERITY
TL;DR
Young America Capital operated for nearly five years with an anti-money laundering program so flawed that its own procedures claimed the firm had no obligation to monitor suspicious activity. Despite advising high-risk cannabis and life sciences deals, the firm used generic retail-trading red flags that had nothing to do with its actual business. After ignoring a 2020 SEC warning and two years of audit recommendations, the firm paid just $50,000 and promised to fix its systems.
This is what happens when compliance becomes optional and fines become cost-of-doing-business line items.
$50,000
Total fine for five years of AML failures
50
Registered representatives working under hollow safeguards
5 years
Period of documented compliance failures
60 days
Time given to remediate systemic problems
The Allegations: A Breakdown
Core Allegations
What they did · 8 points
| 01 | Young America Capital’s written procedures falsely stated the firm had no obligation to monitor or report suspicious activity because it does not hold retail brokerage accounts. Federal law requires all broker-dealers to report suspicious transactions regardless of account type. | high |
| 02 | The firm received a warning from the SEC in 2020 about this erroneous language but left it unchanged in its procedures for years afterward. | high |
| 03 | Young America included red flags in its procedures only for retail trading activities like money movements and securities trades, even though the firm does not hold such accounts. The procedures contained zero red flags for the firm’s actual business of investment banking and merger advisory work. | high |
| 04 | The firm added guidance on marijuana-related suspicious activity reports in 2022, then removed that same guidance later in 2022, even while continuing to work with marijuana-related businesses. | high |
| 05 | Annual independent testing reports in both 2022 and 2023 recommended the firm revise its procedures to include red flags tailored to its business. As of the 2025 settlement, the firm still had not made those changes. | high |
| 06 | The firm provided no guidance to staff on how to detect, monitor, review, or document potential suspicious transactions in its investment banking or merger advisory work. | high |
| 07 | Young America’s AML training was generic and failed to instruct registered representatives about red flags that could occur in investment banking deals. The training contained no reference to marijuana-related risks despite the firm’s work in that sector. | medium |
| 08 | The firm does not review potential investment banking or merger and acquisition transactions to detect suspicious activity, consistent with its flawed written procedures. | high |
Regulatory Failures
How oversight broke down · 6 points
| 01 | FINRA Rule 3310 requires each member firm to develop an AML program reasonably designed to achieve compliance with the Bank Secrecy Act. Young America’s program failed this basic standard from at least August 2020 forward. | high |
| 02 | Federal regulation 31 CFR 1023.320 requires broker-dealers to file suspicious activity reports when transactions are relevant to possible violations of law. Young America’s procedures denied this obligation applied to the firm. | high |
| 03 | FINRA issued detailed guidance in May 2019 through Regulatory Notice 19-18 reminding broker-dealers of their duty to look for red flags of suspicious activity. Young America ignored this guidance. | medium |
| 04 | The Financial Crimes Enforcement Network issued guidance in February 2014 clarifying when to file suspicious activity reports concerning marijuana-related businesses. Young America removed such guidance from its procedures in 2022. | medium |
| 05 | NASD Notice to Members 02-21 advised broker-dealers to tailor AML programs to fit their business, taking into account the types of transactions their customers engage in. Young America used boilerplate retail-trading procedures instead. | medium |
| 06 | The firm violated FINRA Rules 3310(a), 3310(e), 3310(f)(ii), and 2010, covering suspicious transaction reporting, training requirements, ongoing customer due diligence, and high standards of commercial honor. | high |
Profit Over People
Cost-cutting at public expense · 5 points
| 01 | Since at least 2020, Young America generated most of its revenue from investment banking and merger advisory fees related to private placements in cannabis, life sciences, and technology sectors. | medium |
| 02 | The firm advised numerous issuers and companies in high-risk sectors while maintaining procedures that explicitly denied any obligation to monitor those deals for suspicious activity. | high |
| 03 | Building tailored red-flag systems, hiring compliance analysts, and filing suspicious activity reports costs money without generating deal fees. The firm externalized these costs onto regulators and society. | medium |
| 04 | The $50,000 fine represents a fraction of what a single mid-market advisory deal generates in fees. The penalty functions as an affordable license to continue operating rather than a meaningful deterrent. | high |
| 05 | Each year of delay between the 2020 warning and the 2025 settlement allowed the firm to close lucrative deals without the burden of proper AML controls, letting profits accrue while sanctions arrived years later at a discount. | medium |
Economic Fallout
Who pays the price · 5 points
| 01 | When investment banks fail to vet capital raises, illicit funds distort legitimate markets, inflate asset bubbles, and funnel capital away from community-oriented businesses. | medium |
| 02 | Every undetected suspicious transfer forces taxpayers to shoulder higher enforcement budgets and erodes faith in financial institutions, ultimately raising borrowing costs for small enterprises. | medium |
| 03 | Weak AML oversight means dirty money linked to environmental offenses or illicit drug trafficking can mingle with legitimate funds, indirectly financing harmful activity elsewhere. | medium |
| 04 | The firm’s approximately 50 registered representatives worked under hollow compliance guardrails, each empowered to shepherd millions in private capital through deals that received zero scrutiny for money laundering risks. | high |
| 05 | Social costs of investigations, lost investor confidence, and distorted capital markets get shuffled onto taxpayers and honest businesses while the firm keeps its deal fees. | medium |
Worker Exploitation
Staff left unprotected · 4 points
| 01 | Registered representatives received generic AML training that left them ill-equipped to detect wrongdoing in the firm’s actual investment banking business, placing their careers and licenses in jeopardy. | medium |
| 02 | The training was not tailored to the firm’s business model and failed to instruct representatives about red flags of suspicious transactions in investment banking and merger advisory work. | medium |
| 03 | Training contained no reference to marijuana-related risks despite the firm’s work advising cannabis companies, leaving staff ignorant of laundering schemes specific to that sector. | medium |
| 04 | The broader workforce including administrative staff, analysts, and support vendors operated inside a corporate culture signaling that minimal compliance is good enough, normalizing shortcuts and amplifying workplace stress. | low |
Community Impact
Local lives undermined · 4 points
| 01 | Young America Capital is located in Mamaroneck, New York, with one registered branch office, but its private-placement deals reach national markets across multiple high-risk sectors. | low |
| 02 | When deals are vetted through a paper-thin AML program, illicit cash can wash into mainstream projects, warping local credit markets, feeding inflated valuations, and increasing borrowing costs for honest small businesses. | medium |
| 03 | By declaring in its own manuals that it had no obligation to monitor suspicious transactions, the firm effectively invited bad actors to exploit legitimate entrepreneurs who relied on its advisory network for growth capital. | high |
| 04 | Repeated headlines of compliance failures cause community investors to retreat to cash, stalling neighborhood revitalization efforts and economic development. | medium |
Corporate Accountability Failures
No real consequences · 6 points
| 01 | The settlement requires only that a member of senior management certify within 60 days that the firm has remediated the issues and implemented proper systems. No executive is barred from the industry. | high |
| 02 | No clawbacks threaten past bonuses earned during the years when the firm operated with deficient AML controls. | medium |
| 03 | The firm waived its right to a hearing, streamlining the process but also limiting public scrutiny of internal emails, memos, or board minutes that could reveal conscious disregard. | medium |
| 04 | Young America specifically and voluntarily waived any right to claim inability to pay the monetary sanction, indicating the $50,000 fine poses no financial hardship. | medium |
| 05 | The settlement bars the firm from publicly denying any finding or creating the impression the agreement is without factual basis, but allows it to portray the censure as a routine resolution. | low |
| 06 | FINRA may make public announcements about the agreement, but the modest penalty and lack of executive accountability mean the reputational damage is minimal. | low |
Exploiting Delay
Strategic use of time · 5 points
| 01 | Regulators first flagged the firm’s flawed procedures in 2020 through an SEC warning. The erroneous language remained unchanged for years. | high |
| 02 | Independent testers recommended tailored red flags in the firm’s 2022 annual AML testing report. The firm did not implement the recommendation. | high |
| 03 | The July 2023 annual AML independent testing report again recommended the firm revise procedures to include red flags tailored to its business. As of the 2025 settlement, the firm still had not done so. | high |
| 04 | After the firm received a FINRA examination exception in 2022, it revised procedures to include red flags, but chose retail-trading red flags that did not apply to its investment banking business. | medium |
| 05 | Each year of inaction allowed lucrative deals to close unimpeded while profits accrued immediately. Sanctions arrived years later at a fixed dollar amount that did not scale with revenue. | high |
The Bottom Line
What this case reveals · 5 points
| 01 | A suburban investment bank monetized opaque private deals in high-risk sectors while disclaiming basic anti-money laundering responsibilities for nearly five years. | high |
| 02 | The firm ignored warnings from the SEC, FINRA examiners, and its own independent auditors across multiple years, demonstrating conscious disregard for regulatory obligations. | high |
| 03 | The $50,000 fine equals a rounding error compared to the firm’s investment banking revenue, sending a clear market signal that violations are affordable and enforcement is reactive. | high |
| 04 | No executives face personal consequences, no bonuses are clawed back, and the firm can resume business immediately after filing a compliance certification, leaving communities to absorb unseen costs. | medium |
| 05 | The case fits a global pattern where financial firms treat AML compliance as an optional cost, pay modest fines years later, and face no prison terms or industry bars. | medium |
Timeline of Events
March 2010
Young America Capital LLC becomes a FINRA member firm.
February 2014
FinCEN issues guidance clarifying BSA expectations for financial institutions providing services to marijuana-related businesses.
May 2019
FINRA issues Regulatory Notice 19-18 providing detailed guidance on detecting and reporting suspicious transactions.
August 2020
Young America’s AML compliance failures begin as documented in the settlement. The firm’s procedures falsely claim no obligation to monitor suspicious activity.
2020
The SEC warns Young America about erroneous language in its written supervisory procedures. The firm does not correct the language.
2022
The firm receives a FINRA examination exception regarding its AML procedures.
2022
Annual AML independent testing recommends the firm revise procedures to include red flags tailored to its business.
2022
Young America revises procedures to include generic retail-trading red flags that do not apply to its investment banking business.
2022
The firm adds guidance on marijuana-related suspicious activity reports to its procedures, then removes that guidance later the same year.
July 2023
Annual AML independent testing report again recommends the firm revise procedures to include business-specific red flags.
February 17, 2025
Young America Capital signs Letter of Acceptance, Waiver, and Consent, accepting censure and $50,000 fine.
February 26, 2025
FINRA accepts the settlement agreement.
Direct Quotes from the Legal Record
QUOTE 1
The firm falsely claimed no reporting duty
allegations
“The firm’s written supervisory procedures (WSPs) state that the firm has no obligation to monitor for or report suspicious activity because it does not hold retail brokerage accounts.”
💡 This language directly contradicts federal law requiring all broker-dealers to report suspicious transactions regardless of account type.
QUOTE 2
The SEC warned them in 2020
delay_tactics
“Despite receiving a warning in 2020 from the SEC, this erroneous language remains in the firm’s WSPs.”
💡 The firm received explicit notice that its procedures were wrong but chose to leave them unchanged for years.
QUOTE 3
No guidance on how to detect suspicious activity
allegations
“Since August 2020, the firm’s WSPs also have failed to provide any guidance regarding how to detect or monitor for suspicious transactions and how to conduct or document a review of an identified red flag.”
💡 Staff had no instructions whatsoever on spotting money laundering in the firm’s actual investment banking deals.
QUOTE 4
Red flags for the wrong business
allegations
“The included red flags were not tailored to the firm’s business. For example, the firm only included red flags related to activities, such as certain types of money movements or securities trades, that occur in retail brokerage accounts even though the firm does not hold such accounts.”
💡 The firm used boilerplate compliance language for activities it does not even conduct while ignoring its actual high-risk advisory work.
QUOTE 5
Auditors told them twice to fix it
delay_tactics
“In July 2023, the firm’s annual AML independent testing report again recommended that the firm revise its procedures to include red flags tailored to its business. To date, the firm’s WSPs still do not contain any red flags tailored to its business.”
💡 The firm ignored repeated audit findings over multiple years, showing willful disregard for remediation.
QUOTE 6
No review of actual deals
profit
“Consistent with its WSPs, the firm does not review potential investment banking or merger and acquisition transactions to detect suspicious activity.”
💡 The firm’s revenue-generating deals received zero scrutiny for money laundering risks.
QUOTE 7
Cannabis guidance removed
allegations
“Although the firm amended its WSPs in 2022 to include guidance regarding whether and when a SAR concerning a marijuana-related business may be warranted, this guidance was removed later that same year and is not presently included in the firm’s WSPs even though the firm continued to work with marijuana-related businesses.”
💡 The firm stripped out critical sector-specific guidance while continuing to profit from that exact sector.
QUOTE 8
Generic training, no cannabis risks
workers
“Since at least 2020, the firm’s AML training was not tailored to its business model and failed to instruct its registered representatives about red flags of suspicious transactions that could occur in connection with its investment banking and merger and acquisition advisory business. Instead, the firm’s training was generic, contained no reference to marijuana-related risks, and concentrated on potential suspicious transactions in retail brokerage accounts held at the firm.”
💡 Fifty registered representatives received training on retail trading scenarios that never occur at the firm while being left ignorant of actual risks in cannabis and biotech deals.
QUOTE 9
Working in high-risk sectors
profit
“Young America’s primary business is providing investment banking and mergers and acquisitions advisory services to a wide variety of businesses, including those in the cannabis, life sciences, and technology, media, and telecommunications sectors.”
💡 The firm chose to work in sectors with elevated money laundering risks while maintaining deficient controls.
QUOTE 10
Most revenue from private placements
profit
“Since at least 2020, Young America generated most of its revenue from investment banking and merger and acquisition advisory fees related to private placements.”
💡 The firm’s core profit engine was the exact business line it failed to monitor for suspicious activity.
QUOTE 11
Fifty representatives under hollow safeguards
economic
“The firm, which is located in Mamaroneck, New York, has approximately 50 registered representatives and has one registered branch office.”
💡 Dozens of licensed professionals were empowered to handle complex deals without proper AML guidance or oversight.
QUOTE 12
Federal law requires all broker-dealers to report
regulatory
“The firm must, however, report any suspicious transaction conducted or attempted by, at or through the broker-dealer that meet the criteria set forth in 31 C.F.R. § 1023.320, regardless of whether the firm holds retail brokerage accounts.”
💡 This sentence destroys the firm’s core excuse that its lack of retail accounts exempted it from AML duties.
Frequently Asked Questions
What did Young America Capital do wrong?
The firm operated for five years with an anti-money laundering program that falsely claimed it had no obligation to monitor suspicious transactions. Its procedures used generic retail-trading red flags even though it does not hold retail accounts, and it provided no guidance on detecting money laundering in its actual investment banking business.
Did the firm know its procedures were wrong?
Yes. The SEC warned the firm in 2020 that its procedures contained erroneous language. Independent auditors recommended fixes in 2022 and again in 2023. As of the 2025 settlement, the firm still had not corrected the core problems.
What sectors did Young America work in?
The firm provided investment banking and merger advisory services to cannabis companies, life sciences firms, and technology, media, and telecommunications businesses. These sectors carry elevated money laundering risks.
How much was the fine?
FINRA fined Young America Capital $50,000. The settlement also includes a censure and requires the firm to certify within 60 days that it has fixed its AML program.
Is $50,000 a meaningful penalty for a company like this?
No. The firm generates most of its revenue from investment banking advisory fees on private placements. A single mid-market deal can produce fees worth ten times the penalty amount.
Did any executives face personal consequences?
No. The settlement does not bar any individual from the securities industry, claw back any bonuses, or impose personal fines on executives.
What did the firm’s training materials cover?
The training was generic and focused on retail brokerage account scenarios that do not occur at the firm. It contained no information about marijuana-related money laundering risks even though the firm advised cannabis companies.
How many people work at Young America Capital?
The firm has approximately 50 registered representatives. All of them worked under the deficient AML procedures and received inadequate training.
Why did the firm remove cannabis guidance from its procedures?
In 2022, the firm added guidance on when to file suspicious activity reports concerning marijuana-related businesses, then removed that guidance later the same year. The settlement does not explain why, but the firm continued working with cannabis companies after stripping out the guidance.
What can I do if I invested through this firm or a company it advised?
Review any investment banking deals you participated in between 2020 and 2025. If you suspect your money mingled with suspicious funds because of the firm’s lack of oversight, consult a securities attorney about your options. You can also file a tip with FINRA or FinCEN if you have information about specific suspicious transactions.
You can read about this scandal on FINRA’s website: https://www.finra.org/sites/default/files/fda_documents/2021069389701%20Young%20America%20Capital%20LLC%20CRD%20150443%20AWC%20vr%20%282025-1743207613247%29.pdf
💡 Explore Corporate Misconduct by Category
Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.
- 💀 Product Safety Violations — When companies risk lives for profit.
- 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
- 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
- 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
- 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.
